Extracellular Vesicles as Markers and Mediators in Sepsis

Abstract

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It remains a highly lethal condition in which current tools for early diagnosis and therapeutic decision-making are far from ideal. Extracellular vesicles (EVs), 30 nm to several micrometers in size, are released from cells upon activation and apoptosis and express membrane epitopes specific for their parental cells. Since their discovery two decades ago, their role as biomarkers and mediators in various diseases has been intensively studied. However, their potential importance in the sepsis syndrome has gained attention only recently. Sepsis and EVs are both complex fields in which standardization has long been overdue. In this review, several topics are discussed. First, we review current studies on EVs in septic patients with emphasis on their variable quality and clinical utility. Second, we discuss the diagnostic and therapeutic potential of EVs as well as their role as facilitators of cell communication via micro RNA and the relevance of micro-organism-derived EVs. Third, we give an overview over the potential beneficial but also detrimental roles of EVs in sepsis. Finally, we focus on the role of EVs in selected intensive care scenarios such as coagulopathy, mechanical ventilation and blood transfusion. Overall, the prospect for EV use in septic patients is bright, ranging from rapid and precise (point-of-care) diagnostics, prevention of harmful iatrogenic interventions, to using EVs as guides of individualized therapy. Before the above is achieved, however, the EV research field requires reliable standardization of the current methods and development of new analytical procedures that can close the existing technological gaps.

Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis

“…Microvesicles are known determinants of venous thromboembolism [6]. Indeed, increased numbers of circulating microvesicles have been reported in septic patients [7] and it is therefore possible that…”

Proteomic Profiling of LPS‐Induced Macrophage‐Derived Exosomes Indicates Their Involvement in Acute Liver Injury

“…As mentioned earlier, multiple studies pointed out the significant differences in the contents of exosomes released by macrophages under different conditions . This indicated that exosomes released under different conditions might be involved in different functions and pathological processes.…”

“…Indeed, the protein cargo of exosomes is related to specific cell type and confer features to these exosomes . The existing evidence suggests that extracellular vesicles (EVs) derived from circulating cells such as neutrophilic granulocytes, macrophages, dendritic cells (DCs), and natural killer (NK) cells have an important role as mediators in sepsis . Several protective EV‐related mechanisms were recently revealed, while some EVs from leukocytes can be harmful in sepsis .…”

“…The existing evidence suggests that extracellular vesicles (EVs) derived from circulating cells such as neutrophilic granulocytes, macrophages, dendritic cells (DCs), and natural killer (NK) cells have an important role as mediators in sepsis . Several protective EV‐related mechanisms were recently revealed, while some EVs from leukocytes can be harmful in sepsis . Blocking the release of EVs with GW4869 in a septic mice model had cardioprotective effects .…”

Marrow Fat-Secreted Factors as Biomarkers for Osteoporosis

“…The content of EVs can be internalized by other cells and thus influence the function of recipient cells. Because of these characteristics, the diagnostic and therapeutic utility of EVs has been studied extensively [100][101][102]. Different types of EVs have been defined based on their size, origin, and function, e.g., microvesicles, microparticles, exosomes, and apoptotic bodies [103].…”